A team of researchers led by investigators from Brigham and Women’s Hospital and collaborators has developed a groundbreaking test that combines blood-based biomarkers with a clinical score to accurately identify patients experiencing large vessel occlusion (LVO) stroke. This aggressive type of ischemic stroke, caused by a blockage in a major brain artery, requires swift treatment with mechanical thrombectomy to restore blood flow and prevent severe consequences.
The study, published in the journal Stroke...